AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Organ Preservation

Organ Preservation in Locally Advanced Rectal Cancer NCT03064646NA1 site📍 Elche Fundación para el Fomento de la Investigación Sanitaria y B… · Tests: Organ Preservation Towards Cure Via Only Ultra-short ICB in CSCC NCT06823479Phase 25 sites📍 Maastricht📍 Amsterdam📍 Amsterdam The Netherlands Cancer Institute · Tests: Nivolumab, Ipilumimab AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas NCT07290985Phase 24 sites📍 Los Angeles📍 New Haven📍 Houston American Association for Cancer Research · Tests: Tislelizumab, Leucovorin, Oxaliplatin, Fluorouracil, Zanidatamab HDR Endorectal Brachytherapy With 3D-Printed Guidance and Local Shielding for Rectal Cancer Organ Preservation NCT07786493NA1 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: High-Dose-Rate Endorectal Brachytherapy Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe NCT07585890n/a37 sites📍 Innsbruck📍 Vienna📍 Brussels University Medical Center Groningen · Tests: Endischemic hypothermic oxygenated machine perfusion (any device), Endischemic (back-to-base) normothermic machine perf… Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy NCT07629817Phase 31 site📍 Zhengzhou Henan Cancer Hospital · Tests: Toripalimab + Nab-paclitaxel + Platinum-based Chemotherapy, Radiation with Concurrent Chemotherapy, Radical Esophagecto… Adaptive Radiation Boost for Rectal Cancer NCT07221058Phase 11 site📍 Philadelphia Fox Chase Cancer Center · Tests: Adaptive Radiotherapy Boost Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. NCT06758830Phase 2, Phase 31 site📍 Vilnius National Cancer Center Affiliate of Vilnius University Hosp… · Tests: Radiation Therapy, Chemoradiotherapy, Consolidation Chemotherapy, Surgery, Part two Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA) NCT06991465Phase 21 site📍 Montreal Neil Kopek · Tests: Radiation Therapy, FOLFOX regimen, Capecitabine Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer NCT04703101Phase 11 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Capecitabine, Fluorouracil, Intensity-Modulated Radiation Therapy, Leucovorin, Oxaliplatin Node-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Rectal Cancer NCT07068763Phase 21 site📍 Hangzhou Sir Run Run Shaw Hospital · Tests: Lymph-node-sparing short-course radiotherapy, Capecitabine, PD-1/CTLA-4 inhibitor (Aiparolitoworixureli injection) Avoiding Recooling After Normothermic Machine Perfusion in Liver Transplantation NCT07692490NA14 sites📍 Ancona📍 Bari📍 Bergamo The Mediterranean Institute for Transplantation and Advance… · Tests: No Recooling Before Liver Implantation, Traditional Recooling Before Liver Implantation Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates NCT07292298Phase 23 sites📍 Aurora📍 Rochester📍 Portland University of Colorado, Denver · Tests: High Rare Dose Rectal Brachytherapy Boost In-situ vs Ex-situ Liver Preservation NCT07899853NA3 sites📍 Groningen📍 Leiden📍 Rotterdam Leiden University Medical Center · Tests: In-situ perfusion: aNRP, Ex-situ perfusion: DHOPE/DHOPE-COR-NMP Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer NCT06209099NA1 site📍 Beijing Peking University Cancer Hospital & Institute · Tests: Nonoperative Management (NOM), Local Excision (LE), Total Mesorectal Excision (TME) Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery NCT03051464Phase 2, Phase 34 sites📍 Dallas📍 Montreal📍 Montreal Sir Mortimer B. Davis - Jewish General Hospital · Tests: Complete responders and Non-complete responders, Chemoradiation + EBRT Boost, Chemoradiation + HDRBT Boost MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer NCT04808323Phase 11 site📍 Milwaukee Medical College of Wisconsin · Tests: Capecitabine, Initial Dose of Radiation before Dose Escalation, Cohort A: Dose Escalation Radiation, Cohort B: Dose Esc… LECS Combined With LSNNS for Early Gastric Cancer (LENS Trial) NCT07857668n/a1 site📍 Beijing Peking University People's Hospital · Tests: Procedure: LECS combined with LSNNS Nordic ORgan Preservation Pilot Approach Nonrandomised Single-Arm Trial for Non-Operative Management of Rectal Cancer NCT06328361NA13 sites📍 Tallinn📍 Tallinn📍 Tallinn Tampere University Hospital · Tests: Nonoperative surveillance Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local Excision NCT05772923NA7 sites📍 Nijmegen📍 Eindhoven📍 Amsterdam The Netherlands Cancer Institute · Tests: Contact x-ray brachytherapy, Local excision Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer NCT03594630EARLY Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Chemotherapy, Patient Observation, Questionnaire Administration, Resection of Rectum European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] NCT06137378Phase 29 sites📍 Mannheim📍 Ulm📍 München University of Leipzig · Tests: KEYTRUDA® Local Excision for Organ Preservation in Early REctal Cancer With No Adjuvant Treatment NCT05927584n/a1 site📍 Madrid Fundación de Investigación Biomédica - Hospital Universitar… · Tests: Transanal local excision TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer NCT05646511Phase 334 sites📍 Chiba📍 Ehime📍 Fukuoka National Cancer Center Hospital East · Tests: SCRT, CAPOX, CAPOXIRI Organ Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy NCT07337876Phase 21 site📍 Tübingen University Hospital Tuebingen · Tests: Dose escalated radiotherapy using a 1.5 T MR-Linac A Multicenter Phase II Clinical Study of Neoadjuvant Use of Camrelizumab in Combination With Chemotherapy for Organ Preservation in Esophageal Cancer NCT06869226Phase 21 site📍 Beijing Peking University Cancer Hospital & Institute · Tests: Camrelizumab + Nab-paclitaxel + Cisplatin Staged Kidney Transplantation During Combined Heart/Kidney Transplantation NCT06877169NA1 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: Planned delayed implantation of kidney allograft with ex vivo machine perfusion kidney preservation. Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers NCT06580574Phase 21 site📍 Beijing Peking University · Tests: PD1/PDL1 antibody monotherapy, up to 24 weeks, Intensive immunotherapy plus anti-VEGF treatment, up to 24 weeks, Radica… A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer NCT05939661Phase 22 sites📍 Osaka📍 Osaka Osaka University · Tests: Radiation, Chemotherapy, Surgery Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT) NCT06571708Phase 21 site📍 New York Columbia University · Tests: Gemcitabine, Cisplatin, Cemiplimab, Fianlimab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy